Table 2 Overview of parameters used to match control subjects and (subgroups of) MS patients
|  | Controls (n = 9) | All MS patients (n = 18) | MS Low cortisol (n = 9) | MS High cortisol (n = 9) | MS Severe disease (n = 10) | MS Mild disease (n = 8) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Med | IQR | Med | IQR | Med | IQR | Med | IQR | Med | IQR | Med | IQR | |
Age | 66.5 | 53.0–70.0 | 65 | 48–71 | 58 | 44–69 | 70 | 62–71 | 51 | 40–70 | 70 | 65–79 |
Duration | – | – | 24 | 17–37 | 20 | 11–31 | 29 | 21–48 | 19 | 11–22 | 39 | 30–52 |
Cortisol | – | – | 221 | 86–492 | 86 | 20–178.0 | 492 | 289–669 | 146 | 29–461 | 242 | 183–639 |
PMD | 7:10 | 6:00–10:25 | 7:30 | 6:25–9:20 | 7:45 | 5:30–8:45 | 7:15 | 6:45–10:00 | 7:40 | 6:40–8:25 | 7:15 | 6:20–12:25 |
pH CSF | 7.0 | 6.7–7.1 | 6.4 | 6.3–6.6 | 6.4 | 6.3–6.6 | 6.4 | 6.3–6.6 | 6.5 | 6.3–6.7 | 6.3 | 6.1–6.5 |
RIN | 7.4 | 7.1–8.3 | 7.8 | 7.0–8.3 | 7.7 | 7.0–8.4 | 7.4 | 6.6–7.9 | 7.6 | 7.1–8.3 | 7.7 | 6.9–8.4 |